Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Brown Adipose Tissue Activation by Spinal Cord Stimulation

NCT: NCT04326192 · RECRUITING

NCT IDNCT04326192
StatusRECRUITING
Start Date2021-02-19
Completion2029-12
SponsorOregon Health and Science University (OTHER)
First posted
Last updated

Brief Summary

The objective of this study is to investigate and utilize spinal cord stimulation (SCS) as an effective approach to eliciting weight loss and potentially alleviating Type 2 diabetes mellitus (DM), as evidenced by increasing metabolism of adipose tissue.

Frequently Asked Questions

What is Brown Adipose Tissue Activation by Spinal Cord Stimulation?

Brown Adipose Tissue Activation by Spinal Cord Stimulation is a clinical trial registered under NCT04326192. Current status: RECRUITING.

What is the status of NCT04326192?

The current status of NCT04326192 (Brown Adipose Tissue Activation by Spinal Cord Stimulation) is: RECRUITING.

When did Brown Adipose Tissue Activation by Spinal Cord Stimulation start?

Brown Adipose Tissue Activation by Spinal Cord Stimulation started on 2021-02-19.

Related Devices

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.